 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
| This resource center provides physicians and
healthcare professionals with a clinical overview of TDT's technology,
compares
it to current testing models, and provides a guide for ordering
tests for patients.
Tests developed by TDT for colorectal cancer staging and post-treatment monitoring for recurrence represent significant improvements compared to staging by histopathology and post-treatment monitoring using CEA. TDT tests are being introduced under on-site testing guidelines established by federal CLIA '88 statutes. Included in this section are:
|
|
 |